You are here

  • Home
  • Archive
  • Volume 68, Issue 1
  • Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Article metrics

Article menu

Download PDFPDF

XML
Inflammatory bowel disease
Original article
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

 

Online download statistics by month:

Online download statistics by month: December 2017 to March 2024

AbstractFullPdf
Dec 2017621648200
Jan 2018688745223
Feb 201825624987
Mar 201823723459
Apr 201816316342
May 201815014933
Jun 201810611035
Jul 201811111127
Aug 201812312334
Sep 201810210219
Oct 201811611623
Nov 201817517545
Dec 2018635635154
Jan 2019421406132
Feb 2019305302298
Mar 201922021592
Apr 2019184178118
May 2019187184174
Jun 2019181178159
Jul 2019218209151
Aug 2019233229116
Sep 2019212207145
Oct 2019268257180
Nov 2019209201114
Dec 201914113639
Jan 202017917145
Feb 202013913530
Mar 2020219216105
Apr 202024524069
May 202017217063
Jun 202014314272
Jul 202014213741
Aug 202013312840
Sep 202014814537
Oct 202014413934
Nov 202017216852
Dec 202014113368
Jan 202119819255
Feb 202112412232
Mar 202116215652
Apr 202122822162
May 202120820058
Jun 202115815547
Jul 202110510350
Aug 202114413763
Sep 202117215852
Oct 202116115575
Nov 202114614352
Dec 202115917042
Jan 202215015653
Feb 202226526144
Mar 202218217760
Apr 202213713638
May 202213712941
Jun 202216016134
Jul 202211211128
Aug 202217817139
Sep 202218918032
Oct 202214214739
Nov 202216114438
Dec 2022898424
Jan 202311612158
Feb 202317917647
Mar 202314914029
Apr 202311810741
May 2023938938
Jun 202313312738
Jul 202315814742
Aug 202313512430
Sep 202315514545
Oct 202317917632
Nov 202317116040
Dec 202313011028
Jan 2024886668
Feb 2024898430
Mar 202416414598
Total14163138725129